SIROLIMUS

SIROLIMUS was reported 13673 times

SIROLIMUS is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 COW POX 9 0.8182
1 PIK3CA RELATED OVERGROWTH SPECTRUM 10 0.6250
2 STAPHYLOCOCCAL MEDIASTINITIS 10 0.4545
3 SKIN SQUAMOUS CELL CARCINOMA METASTATIC 25 0.2632
4 AVIAN INFLUENZA 14 0.2188
5 SMOOTH MUSCLE CELL NEOPLASM 90 0.2153
6 FOCAL GLOMERULOSCLEROSIS 22 0.2075
7 KAPOSI SARCOMA INFLAMMATORY CYTOKINE SYNDROME 12 0.2034
8 SKIN GRAFT REJECTION 9 0.1579
9 PROPIONIBACTERIUM INFECTION 16 0.1495
10 BRONCHIOLITIS OBLITERANS SYNDROME 24 0.1371
11 PERIORBITAL INFECTION 11 0.1358
12 TULARAEMIA 13 0.1340
13 SKIN SQUAMOUS CELL CARCINOMA RECURRENT 15 0.1316
14 CHRONIC GRAFT VERSUS HOST DISEASE ORAL 29 0.1184
15 DIVERTICULUM OESOPHAGEAL 12 0.1000
16 CHRONIC GRAFT VERSUS HOST DISEASE IN EYE 20 0.0985
17 INFECTED NEOPLASM 24 0.0964
18 EPIDERMODYSPLASIA VERRUCIFORMIS 16 0.0952
19 PHILADELPHIA POSITIVE CHRONIC MYELOID LEUKAEMIA 9 0.0938
20 INTESTINE TRANSPLANT REJECTION 9 0.0938
21 CHRONIC ALLOGRAFT NEPHROPATHY 73 0.0932
22 HUMAN EHRLICHIOSIS 19 0.0909
23 RENAL GRAFT INFECTION 21 0.0905
24 YERSINIA INFECTION 9 0.0882
25 MELAS SYNDROME 19 0.0880
26 ALOPECIA SCARRING 16 0.0874
27 LYMPHANGIOMA 12 0.0870
28 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 202 0.0861
29 ADJUSTED CALCIUM DECREASED 9 0.0849
30 ADENOVIRUS REACTIVATION 12 0.0833
31 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 77 0.0832
32 CONGENITAL MUSCULOSKELETAL DISORDER OF LIMBS 8 0.0762
33 CHRONIC GRAFT VERSUS HOST DISEASE IN LUNG 13 0.0751
34 MALIGNANT FIBROUS HISTIOCYTOMA 10 0.0741
35 RENAL-LIMITED THROMBOTIC MICROANGIOPATHY 17 0.0739
36 HUMAN HERPESVIRUS 8 INFECTION 43 0.0706
37 COMPLICATIONS OF TRANSPLANTED HEART 15 0.0698
38 GRAFT VERSUS HOST DISEASE IN LIVER 46 0.0642
39 LUNG TRANSPLANT REJECTION 42 0.0636
40 CHRONIC GRAFT VERSUS HOST DISEASE 220 0.0609
41 GRAFT VERSUS HOST DISEASE IN EYE 14 0.0606
42 GINGIVITIS ULCERATIVE 13 0.0605
43 SEVERE ACUTE RESPIRATORY SYNDROME 13 0.0591
44 BACILLARY ANGIOMATOSIS 8 0.0588
45 HUMAN POLYOMAVIRUS INFECTION 31 0.0584
46 POLYOMAVIRUS VIRAEMIA 60 0.0565
47 ADACTYLY 9 0.0559
48 GRAFT VERSUS HOST DISEASE IN SKIN 123 0.0558
49 CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER 20 0.0549
50 CYSTITIS VIRAL 21 0.0548
51 LYMPHOCELE 36 0.0542
52 ALVEOLAR PROTEINOSIS 32 0.0541
53 CHRONIC GRAFT VERSUS HOST DISEASE IN INTESTINE 10 0.0526
54 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 111 0.0521
55 APOPTOSIS 16 0.0518
56 CRYPTOSPORIDIOSIS INFECTION 27 0.0514
57 ADENOVIRUS INFECTION 148 0.0510
58 PNEUMONIA ADENOVIRAL 10 0.0505
59 HERPES ZOSTER MENINGOENCEPHALITIS 18 0.0500
60 TRICHODYSPLASIA SPINULOSA 19 0.0499
61 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 65 0.0494
62 MYCOBACTERIUM HAEMOPHILUM INFECTION 14 0.0490
63 TRANSPLANT REJECTION 384 0.0479
64 HEART TRANSPLANT REJECTION 49 0.0472
65 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 37 0.0470
66 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 239 0.0469
67 KIDNEY FIBROSIS 80 0.0461
68 ENTEROCOLITIS VIRAL 14 0.0461
69 EPSTEIN-BARR VIRAEMIA 51 0.0460
70 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 33 0.0459
71 BK VIRUS INFECTION 152 0.0450
72 PANCREAS TRANSPLANT REJECTION 9 0.0448
73 ACUTE GRAFT VERSUS HOST DISEASE 205 0.0447
74 PLASMABLASTIC LYMPHOMA 16 0.0447
75 CYTOMEGALOVIRUS INFECTION REACTIVATION 197 0.0445
76 BACTERIAL COLITIS 8 0.0444
77 TRANSPLANT FAILURE 109 0.0444
78 LIVER TRANSPLANT REJECTION 78 0.0434
79 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 61 0.0432
80 INTUSSUSCEPTION 41 0.0429
81 GRAFT LOSS 31 0.0428
82 Q FEVER 9 0.0425
83 COMPLICATIONS OF TRANSPLANTED LUNG 13 0.0423
84 CLOSTRIDIAL SEPSIS 10 0.0413
85 HISTOLOGY ABNORMAL 9 0.0407
86 EPSTEIN-BARR VIRUS INFECTION 254 0.0406
87 CYTOMEGALOVIRUS GASTROINTESTINAL INFECTION 12 0.0403
88 THROMBOTIC MICROANGIOPATHY 386 0.0396
89 RENAL TUBULAR ATROPHY 34 0.0385
90 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 106 0.0383
91 GRAFT THROMBOSIS 10 0.0382
92 PARVOVIRUS B19 INFECTION 34 0.0380
93 PTERYGIUM 13 0.0376
94 HEPATIC ARTERY THROMBOSIS 11 0.0375
95 VIRAL HAEMORRHAGIC CYSTITIS 26 0.0365
96 RENAL TUBULAR INJURY 44 0.0362
97 COMPLICATIONS OF TRANSPLANT SURGERY 18 0.0356
98 GRAFT DYSFUNCTION 10 0.0351
99 KIDNEY TRANSPLANT REJECTION 162 0.0337
100 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 110 0.0333
101 CYTOMEGALOVIRUS VIRAEMIA 148 0.0332
102 RETINAL SCAR 15 0.0325
103 TRANSITIONAL CELL CARCINOMA 42 0.0324
104 VIRAEMIA 44 0.0317
105 HUMAN HERPESVIRUS 6 INFECTION REACTIVATION 11 0.0313
106 OBLITERATIVE BRONCHIOLITIS 41 0.0312
107 MORPHOEA 15 0.0310
108 HUMAN HERPESVIRUS 6 INFECTION 58 0.0307
109 MALACOPLAKIA 14 0.0306
110 PULMONARY MUCORMYCOSIS 16 0.0303
111 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 53 0.0300
112 PLEOCYTOSIS 17 0.0292
113 HERPES SIMPLEX REACTIVATION 11 0.0289
114 TYPE III IMMUNE COMPLEX MEDIATED REACTION 16 0.0286
115 GRAFT VERSUS HOST DISEASE 205 0.0285
116 DISSEMINATED VARICELLA ZOSTER VIRUS INFECTION 10 0.0275
117 CYTOMEGALOVIRUS OESOPHAGITIS 10 0.0272
118 MYCOBACTERIUM CHELONAE INFECTION 20 0.0271
119 GLOMERULOSCLEROSIS 17 0.0269
120 ALTERNARIA INFECTION 10 0.0269
121 URINARY TRACT INFECTION PSEUDOMONAL 16 0.0266
122 STREPTOCOCCAL BACTERAEMIA 28 0.0257
123 CITROBACTER INFECTION 11 0.0256
124 LYMPHATIC DISORDER 15 0.0251
125 JC VIRUS INFECTION 40 0.0250
126 COMPLICATIONS OF TRANSPLANTED LIVER 9 0.0250
127 BLOOD CREATINE PHOSPHOKINASE DECREASED 8 0.0244
128 FUSARIUM INFECTION 17 0.0243
129 SCEDOSPORIUM INFECTION 17 0.0241
130 PERICARDITIS CONSTRICTIVE 10 0.0237
131 GASTROENTERITIS NOROVIRUS 31 0.0233
132 RETICULOCYTE COUNT DECREASED 10 0.0232
133 PNEUMONIA CYTOMEGALOVIRAL 45 0.0231
134 ABDOMINAL WALL ABSCESS 15 0.0231
135 OTITIS MEDIA ACUTE 17 0.0231
136 GRAFT VERSUS HOST DISEASE IN LUNG 11 0.0230
137 NOCARDIOSIS 57 0.0223
138 TOXOPLASMOSIS 24 0.0222
139 TRACHEOBRONCHITIS 17 0.0221
140 LINEAR IGA DISEASE 36 0.0216
141 COMPLICATIONS OF TRANSPLANTED KIDNEY 49 0.0216
142 METASTATIC SQUAMOUS CELL CARCINOMA 11 0.0215
143 CEREBRAL TOXOPLASMOSIS 20 0.0214
144 CYTOMEGALOVIRUS INFECTION 355 0.0213
145 ACINETOBACTER INFECTION 23 0.0210
146 DIAPHRAGMATIC HERNIA 13 0.0210
147 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 17 0.0209
148 CYTOMEGALOVIRUS COLITIS 48 0.0209
149 PULMONARY CAVITATION 18 0.0207
150 HYPERTRIGLYCERIDAEMIA 121 0.0206
151 BLASTOMYCOSIS 10 0.0206
152 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 12 0.0203
153 KAPOSI'S SARCOMA 10 0.0199
154 CAT SCRATCH DISEASE 8 0.0199
155 SQUAMOUS CELL CARCINOMA OF SKIN 120 0.0199
156 TRANSPLANT DYSFUNCTION 35 0.0196
157 NEUROENDOCRINE CARCINOMA OF THE SKIN 19 0.0194
158 ADRENAL MASS 16 0.0193
159 ZYGOMYCOSIS 9 0.0192
160 NECROTISING RETINITIS 12 0.0187
161 NEPHROGENIC DIABETES INSIPIDUS 21 0.0182
162 CATARACT SUBCAPSULAR 11 0.0180
163 ADRENAL SUPPRESSION 15 0.0178
164 OESOPHAGITIS ULCERATIVE 12 0.0175
165 ENTEROVIRUS INFECTION 15 0.0174
166 VARICELLA ZOSTER VIRUS INFECTION 36 0.0173
167 RENAL TRANSPLANT FAILURE 17 0.0172
168 RETROPERITONEAL LYMPHADENOPATHY 9 0.0171
169 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 27 0.0168
170 CENTRAL NERVOUS SYSTEM LYMPHOMA 23 0.0167
171 METAPNEUMOVIRUS INFECTION 13 0.0166
172 HEPATITIS E 26 0.0165
173 URETERIC STENOSIS 13 0.0162
174 PNEUMATOSIS INTESTINALIS 46 0.0161
175 BRONCHOPULMONARY ASPERGILLOSIS 125 0.0161
176 KLEBSIELLA SEPSIS 18 0.0160
177 CYTOMEGALOVIRUS CHORIORETINITIS 31 0.0159
178 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 19 0.0158
179 PARAINFLUENZAE VIRUS INFECTION 24 0.0158
180 ROTAVIRUS INFECTION 9 0.0156
181 GRAFT COMPLICATION 9 0.0153
182 ASPERGILLOSIS 20 0.0153
183 KLEBSIELLA INFECTION 77 0.0152
184 CORYNEBACTERIUM INFECTION 8 0.0150
185 PULMONARY NOCARDIOSIS 12 0.0146
186 CAMPYLOBACTER INFECTION 12 0.0144
187 FUNGAL SEPSIS 12 0.0144
188 TRACHEITIS 11 0.0144
189 BACTERIAL SEPSIS 47 0.0144
190 VENOOCCLUSIVE DISEASE 36 0.0144
191 BACILLUS INFECTION 9 0.0142
192 BRAIN ABSCESS 36 0.0142
193 HYPERTROPHIC CARDIOMYOPATHY 22 0.0142
194 HYPOGAMMAGLOBULINAEMIA 92 0.0140
195 MENINGITIS VIRAL 19 0.0138
196 HERPES ZOSTER DISSEMINATED 11 0.0137
197 PNEUMONIA STREPTOCOCCAL 15 0.0137
198 SPUTUM PURULENT 9 0.0137
199 ENTEROCOCCAL SEPSIS 11 0.0136
200 STREPTOCOCCAL SEPSIS 16 0.0135
201 DYSPLASIA 16 0.0133
202 NEPHROPATHY TOXIC 149 0.0133
203 BLADDER TRANSITIONAL CELL CARCINOMA 19 0.0133
204 SCLERODERMA 48 0.0132
205 VENOOCCLUSIVE LIVER DISEASE 65 0.0131
206 ENTEROBACTER INFECTION 22 0.0131
207 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 11 0.0130
208 DIFFUSE ALVEOLAR DAMAGE 15 0.0130
209 PULMONARY TOXICITY 91 0.0129
210 SYSTEMIC MYCOSIS 15 0.0128
211 DELAYED GRAFT FUNCTION 9 0.0127
212 JARISCH-HERXHEIMER REACTION 9 0.0126
213 PNEUMONIA INFLUENZAL 15 0.0126
214 CHYLOTHORAX 9 0.0125
215 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 33 0.0124
216 INFECTION REACTIVATION 14 0.0122
217 ENTEROCOCCAL INFECTION 59 0.0122
218 IGA NEPHROPATHY 20 0.0120
219 PNEUMOCYSTIS JIROVECII INFECTION 14 0.0117
220 PSEUDOMONAL BACTERAEMIA 10 0.0117
221 PULMONARY MYCOSIS 9 0.0116
222 MYCOPLASMA INFECTION 9 0.0115
223 EJECTION FRACTION ABNORMAL 14 0.0114
224 ANOGENITAL WARTS 10 0.0112
225 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 107 0.0112
226 PSEUDOMONAS INFECTION 96 0.0112
227 CHRONIC HEPATITIS 9 0.0111
228 PNEUMONIA PSEUDOMONAL 17 0.0111
229 HEART TRANSPLANT 10 0.0110
230 PAPILLOMA VIRAL INFECTION 18 0.0109
231 ILEAL ULCER 11 0.0109
232 MENINGITIS CRYPTOCOCCAL 19 0.0109
233 ESCHERICHIA TEST POSITIVE 13 0.0109
234 OPPORTUNISTIC INFECTION 20 0.0108
235 APLASTIC ANAEMIA 56 0.0107
236 URINARY TRACT INFECTION ENTEROCOCCAL 10 0.0107
237 HISTOPLASMOSIS DISSEMINATED 17 0.0107
238 CAROTID ARTERY THROMBOSIS 9 0.0106
239 AUTOIMMUNE HAEMOLYTIC ANAEMIA 36 0.0105
240 ESCHERICHIA INFECTION 85 0.0103
241 RHINOVIRUS INFECTION 40 0.0103
242 GLOMERULONEPHRITIS 25 0.0102
243 MASTOIDITIS 10 0.0102
244 PNEUMONIA PNEUMOCOCCAL 15 0.0101
245 ASPERGILLUS INFECTION 66 0.0100
246 CYSTITIS HAEMORRHAGIC 40 0.0099
247 MOUTH ULCERATION 208 0.0099
248 ENCEPHALITIS VIRAL 12 0.0099
249 PNEUMOCYSTIS JIROVECII PNEUMONIA 99 0.0098
250 PNEUMONIA KLEBSIELLA 18 0.0098
251 NOROVIRUS INFECTION 14 0.0097
252 SQUAMOUS CELL CARCINOMA 90 0.0096
253 PNEUMONIA FUNGAL 37 0.0094
254 ESCHERICHIA BACTERAEMIA 22 0.0093
255 APLASIA PURE RED CELL 32 0.0093
256 MUCORMYCOSIS 24 0.0092
257 THERAPY PARTIAL RESPONDER 144 0.0092
258 LIVEDO RETICULARIS 19 0.0091
259 SECONDARY IMMUNODEFICIENCY 11 0.0091
260 HAEMOLYTIC URAEMIC SYNDROME 21 0.0091
261 NORMOCYTIC ANAEMIA 13 0.0088
262 RENAL ATROPHY 11 0.0088
263 DRUG LEVEL ABOVE THERAPEUTIC 40 0.0087
264 WHITE MATTER LESION 11 0.0087
265 WOUND INFECTION STAPHYLOCOCCAL 15 0.0087
266 GASTROINTESTINAL VIRAL INFECTION 9 0.0086
267 CRYPTOCOCCOSIS 14 0.0086
268 CARDIAC VENTRICULAR THROMBOSIS 11 0.0085
269 ACTINIC KERATOSIS 22 0.0085
270 HERPES SIMPLEX 55 0.0085
271 ACUTE LUNG INJURY 10 0.0084
272 SUSPECTED OFF LABEL USE 38 0.0084
273 UPPER RESPIRATORY TRACT INFLAMMATION 10 0.0083
274 MULTIPLE ORGAN DYSFUNCTION SYNDROME 235 0.0083
275 STEM CELL TRANSPLANT 20 0.0080
276 VARICELLA 19 0.0079
277 IMMUNE THROMBOCYTOPENIA 36 0.0079
278 LIP HAEMORRHAGE 10 0.0078
279 LYMPHOPROLIFERATIVE DISORDER 23 0.0078
280 CUSHINGOID 25 0.0078
281 OPHTHALMIC HERPES ZOSTER 14 0.0078
282 SOFT TISSUE INFECTION 14 0.0076
283 HYPERLIPIDAEMIA 91 0.0076
284 BILE DUCT STENOSIS 9 0.0075
285 HYPERVOLAEMIA 37 0.0075
286 STEROID DIABETES 11 0.0073
287 CLOSTRIDIUM TEST POSITIVE 16 0.0072
288 PYELONEPHRITIS ACUTE 14 0.0071
289 ALVEOLITIS 10 0.0071
290 FUNGAEMIA 11 0.0070
291 B-CELL LYMPHOMA 23 0.0068
292 PROTEINURIA 128 0.0067
293 HEPATIC FIBROSIS 23 0.0067
294 WOUND DEHISCENCE 22 0.0065
295 INCISIONAL HERNIA 9 0.0065
296 ESCHERICHIA URINARY TRACT INFECTION 27 0.0063
297 MYCOBACTERIUM AVIUM COMPLEX INFECTION 17 0.0063
298 DRUG LEVEL INCREASED 104 0.0063
299 PULMONARY ALVEOLAR HAEMORRHAGE 35 0.0062
300 LABELLED DRUG-DRUG INTERACTION ISSUE 9 0.0062
301 LICHENOID KERATOSIS 14 0.0061
302 RENAL TUBULAR NECROSIS 60 0.0061
303 PNEUMOMEDIASTINUM 11 0.0061
304 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 37 0.0061
305 PROCTITIS 17 0.0061
306 ORGANISING PNEUMONIA 30 0.0060
307 SYSTEMIC INFECTION 10 0.0060
308 VACCINATION FAILURE 10 0.0060
309 IMMUNOSUPPRESSION 53 0.0060
310 HEPATITIS B 36 0.0060
311 THROMBOTIC THROMBOCYTOPENIC PURPURA 21 0.0060
312 LIPIDS INCREASED 12 0.0059
313 VASCULAR STENT THROMBOSIS 12 0.0059
314 PULMONARY HAEMORRHAGE 46 0.0059
315 ESCHERICHIA SEPSIS 17 0.0059
316 MYCOBACTERIAL INFECTION 10 0.0058
317 MICROCYTIC ANAEMIA 12 0.0058
318 HISTIOCYTOSIS HAEMATOPHAGIC 17 0.0057
319 LUNG ABSCESS 12 0.0057
320 MUCOSAL INFLAMMATION 149 0.0057
321 ATYPICAL MYCOBACTERIAL INFECTION 8 0.0057
322 METASTATIC MALIGNANT MELANOMA 13 0.0057
323 LYMPHOPENIA 80 0.0057
324 GASTROINTESTINAL STROMAL TUMOUR 15 0.0056
325 DRUG LEVEL BELOW THERAPEUTIC 31 0.0056
326 PNEUMONIA STAPHYLOCOCCAL 11 0.0056
327 PNEUMONIA BACTERIAL 51 0.0056
328 LUNG CONSOLIDATION 15 0.0054
329 DUODENITIS 16 0.0052
330 DIFFUSE LARGE B-CELL LYMPHOMA 40 0.0052
331 APHTHOUS ULCER 40 0.0052
332 HISTOPLASMOSIS 9 0.0051
333 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 278 0.0051
334 CYTOMEGALOVIRUS TEST POSITIVE 9 0.0050
335 CRANIOCEREBRAL INJURY 15 0.0050
336 PORTAL VEIN THROMBOSIS 16 0.0049
337 DRUG RESISTANCE 127 0.0049
338 SEPTIC SHOCK 215 0.0049
339 PNEUMOPERITONEUM 9 0.0049
340 DIARRHOEA HAEMORRHAGIC 45 0.0048
341 LARGE INTESTINAL ULCER 13 0.0048
342 SYSTEMIC CANDIDA 12 0.0048
343 AZOTAEMIA 19 0.0048
344 PNEUMONIA VIRAL 15 0.0047
345 HEPATOSPLENOMEGALY 12 0.0047
346 HYDRONEPHROSIS 35 0.0047
347 ARTHRITIS BACTERIAL 19 0.0046
348 GRANULOMA 16 0.0046
349 PYELONEPHRITIS 40 0.0046
350 PORTAL HYPERTENSION 14 0.0045
351 ENTERITIS 29 0.0045
352 DYSLIPIDAEMIA 23 0.0045
353 RENAL TRANSPLANT 16 0.0044
354 NEPHROPATHY 41 0.0044
355 BACTERAEMIA 52 0.0044
356 HYPOALBUMINAEMIA 34 0.0044
357 CALCIPHYLAXIS 8 0.0044
358 LYMPHOEDEMA 30 0.0043
359 ENCEPHALITIS 30 0.0043
360 OESOPHAGEAL CANDIDIASIS 17 0.0043
361 OPTIC NEUROPATHY 9 0.0042
362 MASTICATION DISORDER 13 0.0042
363 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 35 0.0042
364 DIASTOLIC DYSFUNCTION 13 0.0042
365 HEPATOCELLULAR CARCINOMA 32 0.0042
366 MULTIPLE-DRUG RESISTANCE 13 0.0042
367 HERPES VIRUS INFECTION 24 0.0042
368 STAPHYLOCOCCAL BACTERAEMIA 18 0.0041
369 GASTROENTERITIS 60 0.0041
370 ORAL DISORDER 30 0.0041
371 GASTROINTESTINAL ULCER 9 0.0041
372 CLOSTRIDIUM DIFFICILE COLITIS 43 0.0041
373 HYPERCHOLESTEROLAEMIA 39 0.0040
374 SKIN EROSION 13 0.0040
375 LEUKOENCEPHALOPATHY 15 0.0040
376 HEPATIC NECROSIS 15 0.0040
377 NECROTISING FASCIITIS 14 0.0040
378 URINARY TRACT INFECTION BACTERIAL 10 0.0040
379 PATHOGEN RESISTANCE 36 0.0039
380 DRUG LEVEL DECREASED 40 0.0039
381 HIGH DENSITY LIPOPROTEIN DECREASED 13 0.0039
382 CHOLANGITIS 24 0.0039
383 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 29 0.0039
384 STAPHYLOCOCCAL SEPSIS 19 0.0038
385 PULSELESS ELECTRICAL ACTIVITY 16 0.0038
386 LUNG OPACITY 10 0.0038
387 DERMATITIS ACNEIFORM 23 0.0038
388 BLOOD CREATININE INCREASED 246 0.0038
389 BACTERIAL INFECTION 70 0.0037
390 ACUTE MYELOID LEUKAEMIA RECURRENT 8 0.0037
391 CLOSTRIDIUM DIFFICILE INFECTION 81 0.0037
392 BRONCHIECTASIS 25 0.0037
393 GINGIVITIS 20 0.0037
394 FAILURE TO THRIVE 19 0.0037
395 BASAL CELL CARCINOMA 57 0.0036
396 NEPHROGENIC SYSTEMIC FIBROSIS 11 0.0036
397 LUNG INFILTRATION 32 0.0036
398 IRITIS 11 0.0036
399 ADENOCARCINOMA 8 0.0036
400 RENAL TUBULAR DISORDER 10 0.0036
401 ABDOMINAL INFECTION 9 0.0035
402 CYTOPENIA 43 0.0035
403 ACUTE RESPIRATORY DISTRESS SYNDROME 62 0.0035
404 METASTATIC NEOPLASM 15 0.0035
405 MULTI-ORGAN FAILURE 60 0.0035
406 VENTRICULAR DYSFUNCTION 9 0.0035
407 METASTASES TO LUNG 40 0.0035
408 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 8 0.0034
409 NECROSIS 19 0.0034
410 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 17 0.0034
411 LIVER ABSCESS 11 0.0034
412 HAEMOLYSIS 26 0.0034
413 NEPHROTIC SYNDROME 23 0.0034
414 MYELOFIBROSIS 10 0.0033
415 SKIN MASS 22 0.0033
416 BLOOD ALBUMIN DECREASED 26 0.0033
417 PNEUMONITIS 89 0.0033
418 FIBROSIS 10 0.0032
419 RENAL IMPAIRMENT 272 0.0032
420 ACUTE PSYCHOSIS 8 0.0032
421 PNEUMOTHORAX 51 0.0032
422 SKIN INFECTION 36 0.0032
423 RESPIRATORY FAILURE 234 0.0032
424 STOMATITIS 194 0.0032
425 PRODUCT USE IN UNAPPROVED INDICATION 792 0.0032
426 BLOOD CREATININE ABNORMAL 11 0.0032
427 BLOOD CREATINE INCREASED 14 0.0032
428 LEUKOPENIA 158 0.0032
429 CANDIDA INFECTION 53 0.0031
430 STAPHYLOCOCCAL INFECTION 103 0.0031
431 ENDOCARDITIS 16 0.0031
432 PERICARDIAL EFFUSION 72 0.0031
433 VENTRICULAR HYPOKINESIA 10 0.0031
434 HYPOPHOSPHATAEMIA 23 0.0031
435 CACHEXIA 16 0.0031
436 HAEMORRHAGIC DIATHESIS 11 0.0031
437 VENOUS THROMBOSIS 12 0.0031
438 THROMBOSIS IN DEVICE 10 0.0030
439 THERAPY NON-RESPONDER 136 0.0030
440 HYPERBILIRUBINAEMIA 31 0.0030
441 RESPIRATORY SYNCYTIAL VIRUS INFECTION 26 0.0030
442 DUODENAL ULCER 21 0.0030
443 METASTASES TO LYMPH NODES 20 0.0030
444 PLEURAL EFFUSION 180 0.0030
445 CLOSTRIDIAL INFECTION 10 0.0030
446 EXERCISE TOLERANCE DECREASED 17 0.0030
447 GASTROINTESTINAL INFLAMMATION 23 0.0029
448 PROTEIN TOTAL DECREASED 11 0.0029
449 GASTROINTESTINAL TOXICITY 14 0.0029
450 ACUTE KIDNEY INJURY 444 0.0029
451 SKIN NECROSIS 15 0.0029
452 PAPILLOEDEMA 13 0.0029
453 TRANSAMINASES INCREASED 64 0.0029
454 HYPERTRANSAMINASAEMIA 20 0.0029
455 RENAL CELL CARCINOMA 14 0.0029
456 MALNUTRITION 32 0.0029
457 ERYTHEMA NODOSUM 10 0.0028
458 PANCYTOPENIA 159 0.0028
459 DRUG INTERACTION 450 0.0028
460 LUNG NEOPLASM 12 0.0028
461 NAIL DISCOLOURATION 11 0.0028
462 FOETAL GROWTH RESTRICTION 17 0.0028
463 ANURIA 24 0.0028
464 BLOOD TRIGLYCERIDES INCREASED 49 0.0028
465 SEPSIS 306 0.0027
466 HAEMODIALYSIS 23 0.0027
467 RHINITIS 22 0.0027
468 HYPOVOLAEMIC SHOCK 13 0.0027
469 FUNGAL INFECTION 90 0.0027
470 PROSTATE CANCER METASTATIC 9 0.0027
471 POTENTIATING DRUG INTERACTION 9 0.0027
472 HEPATIC ENCEPHALOPATHY 25 0.0027
473 MENINGITIS ASEPTIC 12 0.0027
474 CHRONIC SINUSITIS 10 0.0027
475 MYOPATHY 23 0.0027
476 BONE MARROW DISORDER 8 0.0026
477 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 10 0.0026
478 GLOMERULAR FILTRATION RATE DECREASED 32 0.0026
479 UROSEPSIS 24 0.0026
480 RENAL FAILURE CHRONIC 20 0.0026
481 PHARYNGITIS 32 0.0026
482 OLIGURIA 16 0.0026
483 SPLENOMEGALY 30 0.0026
484 BONE MARROW FAILURE 52 0.0026
485 VIRAL UPPER RESPIRATORY TRACT INFECTION 12 0.0025
486 PERIORBITAL OEDEMA 13 0.0025
487 ACUTE RESPIRATORY FAILURE 48 0.0025
488 LIVER TRANSPLANT 9 0.0025
489 OESOPHAGITIS 27 0.0025
490 MALIGNANT MELANOMA 33 0.0025
491 THROMBOCYTOPENIA 272 0.0024
492 OFF LABEL USE 2127 0.0024
493 VASCULAR DEVICE INFECTION 11 0.0024
494 HAEMATOTOXICITY 23 0.0024
495 END STAGE RENAL DISEASE 44 0.0024
496 DISEASE COMPLICATION 11 0.0024
497 REBOUND EFFECT 27 0.0024
498 CHRONIC MYELOID LEUKAEMIA 11 0.0024
499 ATELECTASIS 23 0.0024
500 COVID-19 PNEUMONIA 28 0.0024
501 SHOCK HAEMORRHAGIC 19 0.0023
502 COLITIS 88 0.0023
503 PRE-ECLAMPSIA 11 0.0023
504 DISEASE RECURRENCE 110 0.0023
505 ACUTE MYELOID LEUKAEMIA 36 0.0023
506 DISEASE PROGRESSION 272 0.0023
507 AORTIC STENOSIS 8 0.0023
508 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 67 0.0023
509 VIRAL INFECTION 76 0.0023
510 RESPIRATORY DISTRESS 63 0.0023
511 BRONCHIOLITIS 8 0.0023
512 BLOOD LACTATE DEHYDROGENASE INCREASED 36 0.0023
513 BLOOD UREA INCREASED 38 0.0023
514 ULCER 36 0.0023
515 FEBRILE NEUTROPENIA 148 0.0022
516 RECURRENT CANCER 9 0.0022
517 CUTANEOUS VASCULITIS 8 0.0022
518 INFECTION 313 0.0022
519 MENTAL STATUS CHANGES 60 0.0022
520 NEPHROGENIC ANAEMIA 10 0.0022
521 RHABDOMYOLYSIS 90 0.0022
522 HEPATITIS C 26 0.0022
523 HAEMOLYTIC ANAEMIA 19 0.0021
524 ENCEPHALOPATHY 52 0.0021
525 IMPAIRED HEALING 69 0.0021
526 ILEUS 26 0.0021
527 NYSTAGMUS 11 0.0021
528 HAEMORRHAGIC STROKE 16 0.0020
529 SMALL INTESTINAL OBSTRUCTION 25 0.0020
530 LEUKOCYTOSIS 36 0.0020
531 HYPOXIA 70 0.0020
532 ADRENAL INSUFFICIENCY 24 0.0020
533 ABDOMINAL HERNIA 9 0.0020
534 ASCITES 58 0.0020
535 CELLULITIS 99 0.0020
536 NEUTROPENIC SEPSIS 14 0.0020
537 NEUROTOXICITY 34 0.0019
538 HAEMORRHAGE INTRACRANIAL 29 0.0019
539 PHOTOSENSITIVITY REACTION 32 0.0019
540 HEPATOMEGALY 19 0.0019
541 SKIN LESION 53 0.0019
542 POSTOPERATIVE WOUND INFECTION 13 0.0019
543 INTERSTITIAL LUNG DISEASE 93 0.0019
544 EOSINOPHIL COUNT INCREASED 16 0.0019
545 CHRONIC KIDNEY DISEASE 145 0.0019
546 HEPATOTOXICITY 42 0.0019
547 HYPOVOLAEMIA 11 0.0019
548 SUBCUTANEOUS ABSCESS 9 0.0019
549 TOXICITY TO VARIOUS AGENTS 316 0.0019
550 NEUTROPENIA 254 0.0019
551 CHOLESTASIS 35 0.0018
552 METASTASIS 13 0.0018
553 DEVICE RELATED INFECTION 28 0.0018
554 RESPIRATORY TRACT INFECTION 47 0.0018
555 HEPATIC ENZYME ABNORMAL 9 0.0018
556 LUNG INFECTION 28 0.0018
557 HYPERCALCAEMIA 22 0.0018
558 MYOCARDITIS 20 0.0017
559 RETINAL DETACHMENT 16 0.0017
560 TONSILLITIS 9 0.0017
561 RALES 10 0.0017
562 METASTASES TO LIVER 30 0.0017
563 OVARIAN CYST 17 0.0017
564 MITRAL VALVE INCOMPETENCE 19 0.0017
565 GASTROINTESTINAL INFECTION 15 0.0017
566 ORAL CANDIDIASIS 22 0.0017
567 MENINGITIS 11 0.0016
568 DRUG INTOLERANCE 159 0.0016
569 METASTASES TO CENTRAL NERVOUS SYSTEM 21 0.0016
570 RENAL FAILURE ACUTE 69 0.0016
571 TACHYPNOEA 22 0.0016
572 ABDOMINAL TENDERNESS 8 0.0016
573 ACUTE HEPATIC FAILURE 22 0.0016
574 HYPOKALAEMIA 73 0.0016
575 SKIN CANCER 34 0.0016
576 SHOCK 36 0.0016
577 ENTEROCOLITIS 9 0.0016
578 ELECTROLYTE IMBALANCE 18 0.0015
579 PNEUMONIA 501 0.0015
580 PYREXIA 535 0.0015
581 DRUG TOXICITY 21 0.0015
582 HAEMOPTYSIS 43 0.0015
583 CARDIOGENIC SHOCK 22 0.0015
584 INFLAMMATORY BOWEL DISEASE 15 0.0015
585 GASTRIC ULCER 29 0.0015
586 CARDIAC FAILURE ACUTE 10 0.0015
587 TUBULOINTERSTITIAL NEPHRITIS 28 0.0015
588 HEPATIC FAILURE 45 0.0015
589 COLITIS ISCHAEMIC 10 0.0015
590 GASTRITIS 39 0.0015
591 PULMONARY OEDEMA 66 0.0015
592 UPPER RESPIRATORY TRACT INFECTION 68 0.0015
593 PEMPHIGOID 11 0.0015
594 GENERALISED OEDEMA 18 0.0015
595 HEPATITIS 37 0.0014
596 PULMONARY CONGESTION 19 0.0014
597 COAGULOPATHY 24 0.0014
598 RENAL FAILURE 191 0.0014
599 AUTOIMMUNE DISORDER 14 0.0014
600 TRANSFUSION 15 0.0014
601 PANCREATITIS ACUTE 32 0.0014
602 LOW DENSITY LIPOPROTEIN INCREASED 11 0.0014
603 PAPULE 10 0.0014
604 HEMIPARESIS 24 0.0014
605 LYMPHOCYTE COUNT DECREASED 25 0.0014
606 LYMPHADENOPATHY 50 0.0014
607 METABOLIC ACIDOSIS 45 0.0014
608 OSTEONECROSIS 46 0.0014
609 PERITONITIS 29 0.0014
610 EXPOSURE DURING PREGNANCY 86 0.0014
611 FLUID OVERLOAD 20 0.0014
612 EOSINOPHILIA 24 0.0014
613 RESPIRATORY RATE INCREASED 12 0.0014
614 CARDIOTOXICITY 12 0.0013
615 PULMONARY HYPERTENSION 28 0.0013
616 IMMUNODEFICIENCY 20 0.0013
617 INTESTINAL PERFORATION 15 0.0013
618 GASTROENTERITIS VIRAL 24 0.0013
619 PREMATURE DELIVERY 21 0.0013
620 SKIN ULCER 34 0.0013
621 ECCHYMOSIS 9 0.0013
622 OEDEMA 71 0.0013
623 RESPIRATION ABNORMAL 9 0.0013
624 TREATMENT FAILURE 108 0.0013
625 HYPERGLYCAEMIA 47 0.0013
626 DIABETES MELLITUS 98 0.0013
627 APPENDICITIS 12 0.0013
628 DEFORMITY 12 0.0013
629 ORAL HERPES 25 0.0013
630 ASPIRATION 14 0.0013
631 HEPATIC CIRRHOSIS 24 0.0013
632 MYELOSUPPRESSION 46 0.0013
633 COVID-19 224 0.0013
634 ATAXIA 15 0.0013
635 JAUNDICE 34 0.0013
636 LOW BIRTH WEIGHT BABY 10 0.0013
637 URINE OUTPUT DECREASED 11 0.0013
638 MYELODYSPLASTIC SYNDROME 18 0.0012
639 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 11 0.0012
640 MOUTH HAEMORRHAGE 9 0.0012
641 PHOTOPHOBIA 23 0.0012
642 ANAEMIA 233 0.0012
643 EPILEPSY 37 0.0012
644 LACTIC ACIDOSIS 39 0.0012
645 HEPATIC ENZYME INCREASED 82 0.0012
646 POST PROCEDURAL HAEMORRHAGE 14 0.0012
647 HYPERKALAEMIA 42 0.0012
648 OSTEOPENIA 18 0.0012
649 SKIN PLAQUE 10 0.0012
650 ABNORMAL LOSS OF WEIGHT 8 0.0012
651 GAMMA-GLUTAMYLTRANSFERASE INCREASED 26 0.0012
652 KIDNEY INFECTION 23 0.0012
653 CENTRAL NERVOUS SYSTEM LESION 16 0.0012
654 PLATELET COUNT DECREASED 124 0.0012
655 ORAL PAIN 26 0.0012
656 PRODUCT USE ISSUE 218 0.0012
657 GASTROINTESTINAL HAEMORRHAGE 96 0.0011
658 DRUG-INDUCED LIVER INJURY 36 0.0011
659 FOLLICULITIS 12 0.0011
660 GINGIVAL PAIN 9 0.0011
661 HAEMATURIA 38 0.0011
662 OSTEOMYELITIS 20 0.0011
663 WOUND INFECTION 12 0.0011
664 PRODUCT PRESCRIBING ERROR 26 0.0011
665 SPINAL COMPRESSION FRACTURE 9 0.0011
666 GENERALISED TONIC-CLONIC SEIZURE 18 0.0011
667 ANGIOEDEMA 48 0.0011
668 LUNG DISORDER 53 0.0011
669 PANCREATITIS 57 0.0011
670 RENAL DISORDER 50 0.0011
671 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 25 0.0011
672 DISSEMINATED INTRAVASCULAR COAGULATION 15 0.0011
673 ARTERIOSCLEROSIS 10 0.0011
674 HERPES ZOSTER 61 0.0011
675 HAEMATOCRIT DECREASED 21 0.0011
676 HYPOCALCAEMIA 20 0.0011
677 CONDITION AGGRAVATED 321 0.0011
678 OEDEMA PERIPHERAL 128 0.0010
679 URINARY TRACT INFECTION 179 0.0010
680 GASTROINTESTINAL DISORDER 94 0.0010
681 ANGINA PECTORIS 30 0.0010
682 ACIDOSIS 8 0.0010
683 JOINT RANGE OF MOTION DECREASED 14 0.0010
684 PULMONARY ARTERIAL HYPERTENSION 15 0.0010
685 LIVER FUNCTION TEST INCREASED 22 0.0010
686 THERAPY CHANGE 10 0.0010
687 PERICARDITIS 17 0.0010
688 DYSPNOEA EXERTIONAL 38 0.0010
689 FACE OEDEMA 17 0.0010
690 PULMONARY MASS 15 0.0010
691 PREMATURE BABY 30 0.0010
692 ALANINE AMINOTRANSFERASE INCREASED 61 0.0010
693 RASH MACULO-PAPULAR 22 0.0010
694 INFLAMMATION 51 0.0010
695 BLOOD CHOLESTEROL INCREASED 46 0.0010
696 BLOOD POTASSIUM INCREASED 16 0.0010
697 RED BLOOD CELL COUNT DECREASED 28 0.0010
698 GRAND MAL CONVULSION 9 0.0010
699 HAEMOGLOBIN DECREASED 100 0.0010
700 APPLICATION SITE IRRITATION 12 0.0010
701 BLOOD BILIRUBIN INCREASED 26 0.0010
702 NEOPLASM 11 0.0010
703 DEEP VEIN THROMBOSIS 62 0.0010
704 BRAIN OEDEMA 12 0.0009
705 PULMONARY EMBOLISM 90 0.0009
706 RENAL INJURY 28 0.0009
707 PULMONARY FIBROSIS 18 0.0009
708 LIVER INJURY 23 0.0009
709 BLOOD ALKALINE PHOSPHATASE INCREASED 23 0.0009
710 SKIN REACTION 13 0.0009
711 DIALYSIS 13 0.0009
712 METASTASES TO BONE 15 0.0009
713 TOOTH INFECTION 12 0.0009
714 UPPER GASTROINTESTINAL HAEMORRHAGE 15 0.0009
715 CYANOSIS 14 0.0009
716 STATUS EPILEPTICUS 10 0.0009
717 INTENTIONAL PRODUCT USE ISSUE 77 0.0009
718 DRUG INEFFECTIVE 1150 0.0009
719 HYPERTENSION 184 0.0009
720 CARDIOVASCULAR DISORDER 22 0.0009
721 ASPARTATE AMINOTRANSFERASE INCREASED 46 0.0009
722 MASS 12 0.0009
723 HEPATIC FUNCTION ABNORMAL 32 0.0009
724 ACNE 64 0.0008
725 NODULE 11 0.0008
726 THERAPEUTIC RESPONSE DECREASED 51 0.0008
727 LYMPHOMA 13 0.0008
728 PNEUMONIA ASPIRATION 21 0.0008
729 CHOLECYSTITIS 10 0.0008
730 EJECTION FRACTION DECREASED 13 0.0008
731 IMMUNE SYSTEM DISORDER 11 0.0008
732 DIARRHOEA 530 0.0008
733 HAEMORRHOIDS 16 0.0008
734 MELAENA 18 0.0008
735 DERMATITIS 17 0.0008
736 HAEMATOMA 21 0.0008
737 NEOPLASM MALIGNANT 54 0.0008
738 OBSTRUCTIVE AIRWAYS DISORDER 9 0.0008
739 NERVOUS SYSTEM DISORDER 25 0.0008
740 HYPOMAGNESAEMIA 11 0.0008
741 TREATMENT NONCOMPLIANCE 43 0.0008
742 HYPOPHAGIA 20 0.0008
743 HAEMATOCHEZIA 43 0.0008
744 TENDONITIS 12 0.0008
745 CARDIAC FAILURE 62 0.0008
746 ABSCESS 12 0.0008
747 CYTOKINE RELEASE SYNDROME 15 0.0007
748 SKIN HAEMORRHAGE 11 0.0007
749 C-REACTIVE PROTEIN INCREASED 27 0.0007
750 BODY TEMPERATURE INCREASED 15 0.0007
751 GENERAL PHYSICAL HEALTH DETERIORATION 84 0.0007
752 CYSTITIS 23 0.0007
753 EAR INFECTION 19 0.0007
754 BLOOD CALCIUM DECREASED 8 0.0007
755 SINUS TACHYCARDIA 10 0.0007
756 INTRAOCULAR PRESSURE INCREASED 9 0.0007
757 SEIZURE 81 0.0007
758 UNRESPONSIVE TO STIMULI 18 0.0007
759 BLOOD CREATINE PHOSPHOKINASE INCREASED 20 0.0007
760 CARDIAC ARREST 57 0.0007
761 ABDOMINAL PAIN 159 0.0007
762 CHILLS 78 0.0007
763 FOETAL EXPOSURE DURING PREGNANCY 54 0.0007
764 NEUROPATHY PERIPHERAL 63 0.0007
765 NEOPLASM PROGRESSION 23 0.0007
766 DRY EYE 33 0.0007
767 DIPLOPIA 17 0.0007
768 DIVERTICULITIS 18 0.0006
769 EPISTAXIS 48 0.0006
770 TACHYCARDIA 57 0.0006
771 DRY SKIN 85 0.0006
772 INFLUENZA 71 0.0006
773 RESPIRATORY DISORDER 19 0.0006
774 HEPATOCELLULAR INJURY 9 0.0006
775 ECZEMA 33 0.0006
776 CORONARY ARTERY DISEASE 19 0.0006
777 POST PROCEDURAL COMPLICATION 12 0.0006
778 DEHYDRATION 83 0.0006
779 LIVER FUNCTION TEST ABNORMAL 18 0.0006
780 PRODUCT AVAILABILITY ISSUE 14 0.0006
781 SINUSITIS 63 0.0006
782 CARDIOMYOPATHY 9 0.0006
783 OSTEOPOROSIS 25 0.0006
784 DRUG EFFECT LESS THAN EXPECTED 9 0.0006
785 VENTRICULAR TACHYCARDIA 10 0.0006
786 OXYGEN SATURATION DECREASED 34 0.0006
787 HYPONATRAEMIA 34 0.0006
788 SPINAL FRACTURE 12 0.0006
789 PRODUCT PRESCRIBING ISSUE 13 0.0006
790 ATRIAL FIBRILLATION 58 0.0006
791 COUGH 167 0.0006
792 APPLICATION SITE PAIN 13 0.0006
793 NEUTROPHIL COUNT DECREASED 24 0.0006
794 PRODUCTIVE COUGH 28 0.0006
795 FOOT FRACTURE 11 0.0006
796 ACUTE MYOCARDIAL INFARCTION 17 0.0006
797 MALIGNANT NEOPLASM PROGRESSION 59 0.0006
798 PLASMA CELL MYELOMA 22 0.0006
799 CEREBRAL HAEMORRHAGE 20 0.0006
800 WHITE BLOOD CELL COUNT DECREASED 60 0.0006
801 WEIGHT DECREASED 153 0.0005
802 VOMITING 257 0.0005
803 HEPATIC STEATOSIS 10 0.0005
804 THROMBOSIS 43 0.0005
805 ABORTION SPONTANEOUS 21 0.0005
806 WHITE BLOOD CELL COUNT INCREASED 20 0.0005
807 HOSPITALISATION 79 0.0005
808 HAEMORRHAGE 53 0.0005
809 GOUT 9 0.0005
810 PERIPHERAL SWELLING 76 0.0005
811 CEREBRAL INFARCTION 12 0.0005
812 DECREASED APPETITE 111 0.0005
813 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 12 0.0005
814 WOUND 13 0.0005
815 ALTERED STATE OF CONSCIOUSNESS 10 0.0005
816 SURGERY 27 0.0005
817 RASH ERYTHEMATOUS 22 0.0005
818 MATERNAL EXPOSURE DURING PREGNANCY 41 0.0005
819 HYPOGLYCAEMIA 22 0.0005
820 SKIN IRRITATION 20 0.0004
821 AGITATION 32 0.0004
822 HYPOTENSION 87 0.0004
823 FLUID RETENTION 22 0.0004
824 BRONCHITIS 32 0.0004
825 CONJUNCTIVITIS 8 0.0004
826 AGRANULOCYTOSIS 8 0.0004
827 LIVER DISORDER 19 0.0004
828 COGNITIVE DISORDER 20 0.0004
829 ERYTHEMA 88 0.0004
830 BLOOD SODIUM DECREASED 8 0.0004
831 HEART RATE INCREASED 42 0.0004
832 PRODUCT DOSE OMISSION IN ERROR 12 0.0004
833 LOWER RESPIRATORY TRACT INFECTION 19 0.0004
834 SWOLLEN TONGUE 13 0.0004
835 DYSPNOEA 231 0.0004
836 DYSURIA 15 0.0004
837 LABORATORY TEST ABNORMAL 12 0.0004
838 NAUSEA 319 0.0004
839 INTESTINAL OBSTRUCTION 15 0.0004
840 PROSTATE CANCER 32 0.0004
841 GLYCOSYLATED HAEMOGLOBIN INCREASED 10 0.0004
842 ASTHENIA 148 0.0004
843 MYALGIA 66 0.0004
844 TYPE 2 DIABETES MELLITUS 13 0.0004
845 INTENTIONAL DOSE OMISSION 11 0.0004
846 LETHARGY 22 0.0004
847 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 27 0.0004
848 DYSPHAGIA 36 0.0004
849 THERAPEUTIC RESPONSE UNEXPECTED 17 0.0004
850 COMA 18 0.0004
851 BONE PAIN 22 0.0004
852 PRODUCT DOSE OMISSION ISSUE 110 0.0004
853 MENSTRUATION IRREGULAR 10 0.0004
854 EYE PAIN 21 0.0004
855 LOCALISED INFECTION 9 0.0004
856 RHINORRHOEA 24 0.0004
857 CONVULSION 21 0.0004
858 DEATH 315 0.0004
859 APHASIA 11 0.0004
860 ABDOMINAL DISCOMFORT 61 0.0004
861 RESPIRATORY ARREST 10 0.0004
862 SKIN DISORDER 12 0.0004
863 ILLNESS 37 0.0004
864 NASAL CONGESTION 21 0.0004
865 HEADACHE 223 0.0004
866 RASH 155 0.0004
867 HAEMATEMESIS 9 0.0004
868 FATIGUE 275 0.0004
869 CATARACT 21 0.0004
870 DYSARTHRIA 13 0.0003
871 NIGHT SWEATS 11 0.0003
872 PSYCHOTIC DISORDER 10 0.0003
873 BLISTER 19 0.0003
874 CHOLELITHIASIS 11 0.0003
875 MUSCULAR WEAKNESS 38 0.0003
876 FREQUENT BOWEL MOVEMENTS 9 0.0003
877 IRRITABILITY 20 0.0003
878 VISUAL IMPAIRMENT 41 0.0003
879 ILL-DEFINED DISORDER 20 0.0003
880 CONFUSIONAL STATE 52 0.0003
881 DELIRIUM 11 0.0003
882 THERAPY CESSATION 16 0.0003
883 THERAPY INTERRUPTED 22 0.0003
884 CHEST PAIN 57 0.0003
885 MYOCARDIAL INFARCTION 53 0.0003
886 OROPHARYNGEAL PAIN 28 0.0003
887 BLOOD POTASSIUM DECREASED 9 0.0003
888 PRURITUS 115 0.0003
889 SWELLING 28 0.0003
890 MENTAL DISORDER 13 0.0003
891 GASTROOESOPHAGEAL REFLUX DISEASE 24 0.0003
892 VERTIGO 18 0.0003
893 DISCOMFORT 18 0.0003
894 LIMB DISCOMFORT 9 0.0003
895 COLITIS ULCERATIVE 13 0.0003
896 ANAPHYLACTIC REACTION 16 0.0003
897 TREMOR 48 0.0003
898 POLLAKIURIA 12 0.0003
899 CARDIO-RESPIRATORY ARREST 12 0.0003
900 RASH PRURITIC 15 0.0003
901 URINARY RETENTION 9 0.0003
902 ABDOMINAL DISTENSION 28 0.0003
903 CONTRAINDICATED PRODUCT ADMINISTERED 8 0.0003
904 CARDIAC FAILURE CONGESTIVE 21 0.0003
905 PAIN 160 0.0003
906 NASOPHARYNGITIS 48 0.0003
907 AGGRESSION 13 0.0003
908 CONTUSION 25 0.0003
909 DYSPHONIA 15 0.0003
910 ALOPECIA 50 0.0003
911 SKIN BURNING SENSATION 18 0.0003
912 ABDOMINAL PAIN UPPER 51 0.0002
913 SWELLING FACE 16 0.0002
914 BLINDNESS 10 0.0002
915 ADVERSE DRUG REACTION 22 0.0002
916 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 44 0.0002
917 BLOOD PRESSURE DECREASED 16 0.0002
918 GAIT DISTURBANCE 45 0.0002
919 MEDICATION ERROR 13 0.0002
920 INFLUENZA LIKE ILLNESS 19 0.0002
921 PRODUCT DOSE OMISSION 15 0.0002
922 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 11 0.0002
923 ADVERSE EVENT 21 0.0002
924 WEIGHT INCREASED 51 0.0002
925 DEPRESSED LEVEL OF CONSCIOUSNESS 9 0.0002
926 CHEST DISCOMFORT 23 0.0002
927 PAIN IN EXTREMITY 66 0.0002
928 JOINT SWELLING 27 0.0002
929 LUNG NEOPLASM MALIGNANT 9 0.0002
930 ACCIDENTAL OVERDOSE 8 0.0002
931 SKIN DISCOLOURATION 10 0.0002
932 NECK PAIN 12 0.0002
933 INFUSION RELATED REACTION 14 0.0002
934 MIGRAINE 20 0.0002
935 EYE IRRITATION 12 0.0002
936 HYPERSENSITIVITY 38 0.0002
937 FALL 68 0.0002
938 BLOOD PRESSURE INCREASED 31 0.0002
939 ARTHRALGIA 84 0.0002
940 DYSGEUSIA 15 0.0002
941 SKIN EXFOLIATION 17 0.0002
942 ARTHROPATHY 11 0.0002
943 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 40 0.0002
944 VISION BLURRED 27 0.0002
945 CONSTIPATION 42 0.0002
946 DERMATITIS ATOPIC 10 0.0002
947 CEREBROVASCULAR ACCIDENT 32 0.0002
948 PALPITATIONS 22 0.0002
949 NO ADVERSE EVENT 34 0.0002
950 MALAISE 82 0.0002
951 MUSCLE SPASMS 34 0.0002
952 DYSPEPSIA 18 0.0002
953 CARDIAC DISORDER 17 0.0002
954 BACK PAIN 42 0.0002
955 SYNCOPE 18 0.0002
956 FLATULENCE 10 0.0002
957 PRODUCT SUBSTITUTION ISSUE 10 0.0002
958 DIZZINESS 86 0.0002
959 UNEVALUABLE EVENT 13 0.0002
960 INTENTIONAL PRODUCT MISUSE 15 0.0002
961 ARRHYTHMIA 8 0.0002
962 HYPOAESTHESIA 25 0.0002
963 PARAESTHESIA 26 0.0002
964 HYPERHIDROSIS 21 0.0002
965 URTICARIA 27 0.0002
966 HALLUCINATION 12 0.0002
967 BURNING SENSATION 11 0.0002
968 LOSS OF CONSCIOUSNESS 20 0.0002
969 SLEEP DISORDER 11 0.0002
970 SOMNOLENCE 31 0.0002
971 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 8 0.0002
972 BRADYCARDIA 8 0.0002
973 FLUSHING 15 0.0001
974 MOBILITY DECREASED 10 0.0001
975 BALANCE DISORDER 12 0.0001
976 BLOOD GLUCOSE INCREASED 26 0.0001
977 DEPRESSION 31 0.0001
978 INSOMNIA 36 0.0001
979 ANXIETY 37 0.0001
980 ARTHRITIS 10 0.0001
981 DRY MOUTH 10 0.0001
982 MEMORY IMPAIRMENT 16 0.0001
983 DRUG DOSE OMISSION 19 0.0001
984 INCORRECT DOSE ADMINISTERED 26 0.0001
985 ASTHMA 12 0.0001
986 MUSCULOSKELETAL STIFFNESS 9 0.0001
987 FEELING ABNORMAL 24 0.0001
988 PRODUCT QUALITY ISSUE 12 0.0001
989 OVERDOSE 13 0.0001
990 INJECTION SITE PAIN 15 0.0000